Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Karolinska Development Cash from Financing (TTM): -0.0782M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.0782M |
December 31, 2023 | -0.0758M |
September 30, 2023 | 0.95M |
June 30, 2023 | -0.6638M |
March 31, 2023 | -1.877M |
December 31, 2022 | 23.43M |
September 30, 2022 | 22.41M |
June 30, 2022 | 24.02M |
March 31, 2022 | 25.22M |
December 31, 2021 | -0.0834M |
September 30, 2021 | -0.1351M |
June 30, 2021 | -0.1155M |
March 31, 2021 | -0.0945M |
December 31, 2020 | -0.0731M |
September 30, 2020 | -1.506M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.015M |
June 30, 2018 | -0.0347M |
March 31, 2018 | -0.0383M |
Date | Value |
---|---|
December 31, 2017 | -0.3084M |
September 30, 2017 | -0.3226M |
June 30, 2017 | -0.2729M |
March 31, 2017 | -0.2692M |
December 31, 2016 | 0.0008M |
September 30, 2016 | 0.2781M |
June 30, 2016 | -0.0355M |
March 31, 2016 | -0.5347M |
December 31, 2015 | 39.35M |
September 30, 2015 | 51.66M |
June 30, 2015 | 51.97M |
March 31, 2015 | 52.47M |
December 31, 2014 | 12.58M |
September 30, 2014 | -0.0019M |
June 30, 2014 | -0.3814M |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | -0.0227M |
December 31, 2012 | 0.2171M |
September 30, 2012 | 0.8941M |
June 30, 2012 | -2.645M |
March 31, 2012 | 95.86M |
December 31, 2011 | 95.62M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.877M
Minimum
Mar 2023
25.22M
Maximum
Mar 2022
5.708M
Average
-0.077M
Median
Cash from Financing (TTM) Benchmarks
Abliva AB | 0.0391M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | 11.82M |
Olink Holding AB | 92.50M |
BioInvent International AB | -0.8002M |